Back to User profile » Dr Kun-Chun Chiang
Papers published by Dr Kun-Chun Chiang:
Interferon α-inducible protein 27 is an oncogene and highly expressed in cholangiocarcinoma patients with poor survival
Chiang K, Huang S, Wu RC, Huang SC, Yeh T, Chen M, Hsu JT, Chen L, Kuo SF, Chueh H, Juang H, Hung S, Yeh C, Pang JS
Cancer Management and Research 2019, 11:1893-1905
Published Date: 28 February 2019
MART-10, a newly synthesized vitamin D analog, represses metastatic potential of head and neck squamous carcinoma cells
Yang SW, Tsai CY, Pan YC, Yeh CN, Pang JHS, Takano M, Kittaka A, Juang HH, Chen TC, Chiang KC
Drug Design, Development and Therapy 2016, 10:1995-2002
Published Date: 17 June 2016
PTEN insufficiency modulates ER+ breast cancer cell cycle progression and increases cell growth in vitro and in vivo
Chiang KC, Chen HY, Hsu SY, Pang JHS, Wang SY, Hsu JT, Yeh TS, Chen LW, Kuo SF, Sun CC, Lee JM, Yeh CN, Juang HH
Drug Design, Development and Therapy 2015, 9:4631-4638
Published Date: 13 August 2015
Peritumoral SPARC expression and patient outcome with resectable intrahepatic cholangiocarcinoma
Cheng CT, Chu YY, Yeh CN, Huang SC, Chen MH, Wang SY, Tsai CY, Chiang KC, Chen YY, Ma MC, Liu CT, Chen TW, Yeh TS
OncoTargets and Therapy 2015, 8:1899-1907
Published Date: 28 July 2015